Fluoroscopy and Mobile C-Arms - Global Strategic Business Report 2026

The global market for Fluoroscopy and Mobile C-Arms was valued at US$2.7 Billion in 2025 and is projected to reach US$5 Billion by 2032, growing at a CAGR of 9% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Fluoroscopy and Mobile C-Arms Market - Key Trends and Drivers Summarized

Why Are Fluoroscopy and Mobile C-Arms Becoming Indispensable in Modern Medicine?

Fluoroscopy and mobile C-arms are revolutionizing the field of medical imaging, becoming essential tools in diagnostics and therapeutic procedures. Fluoroscopy provides real-time X-ray imaging, enabling physicians to view dynamic processes within the body, such as the movement of joints or the flow of blood through vessels. Mobile C-arms, a type of fluoroscopic equipment, offer the added benefit of portability, allowing for their use in various settings, including operating rooms and outpatient clinics. The ability to capture high-quality images in real-time has made these technologies invaluable for a range of medical specialties, including orthopedics, cardiology, and gastroenterology. As a result, the demand for fluoroscopy and mobile C-arms continues to grow, driven by their versatility and effectiveness in improving patient outcomes.

How Are Technological Advancements Shaping the Future of Imaging?

Recent technological advancements have significantly enhanced the capabilities of fluoroscopy and mobile C-arms, driving their adoption across the healthcare sector. Innovations such as digital flat-panel detectors have improved image quality while reducing radiation exposure, making procedures safer for both patients and healthcare providers. The integration of artificial intelligence (AI) and machine learning in imaging systems has introduced smart functionalities, such as automated image analysis and enhanced diagnostic accuracy. Furthermore, the development of 3D imaging and digital subtraction angiography (DSA) has expanded the applications of fluoroscopy, particularly in complex vascular and interventional procedures. These technological strides are not only enhancing the clinical utility of fluoroscopy and mobile C-arms but are also attracting significant investments from healthcare providers aiming to upgrade their diagnostic and therapeutic capabilities.

Why Is There a Surge in Demand for Portable Imaging Solutions?

The rise in minimally invasive surgeries and the increasing prevalence of chronic diseases have spurred the demand for portable imaging solutions like mobile C-arms. These devices are particularly valuable in ambulatory surgery centers and outpatient settings, where the need for flexible and efficient imaging solutions is paramount. The trend towards outpatient surgeries, driven by cost-effectiveness and patient convenience, has further accelerated the adoption of mobile C-arms. Additionally, the aging global population and the corresponding increase in surgical procedures have highlighted the need for advanced imaging technologies that can be easily maneuvered within different clinical environments. The ability of mobile C-arms to provide high-resolution images on the spot makes them indispensable for real-time decision-making during surgical interventions, thus driving their widespread adoption.

What Factors Are Driving the Growth in the Fluoroscopy and Mobile C-Arms Market?

The growth in the fluoroscopy and mobile C-arms market is driven by several factors. Firstly, the continuous advancements in imaging technology, such as the development of flat-panel detectors and AI-powered image analysis, are propelling the demand for these devices. The rising number of minimally invasive and outpatient surgeries is expanding the addressable market for mobile C-arms. Furthermore, regulatory approvals and guidelines are strengthening the business case for adopting advanced fluoroscopy systems. The increasing prevalence of chronic diseases and the aging population are also significant drivers, necessitating frequent diagnostic and therapeutic procedures that rely on real-time imaging. Additionally, the integration of fluoroscopy in hybrid operating rooms (ORs) and the growing emphasis on radiation dose management are generating further demand. Government initiatives and funding for healthcare infrastructure, coupled with rising awareness and training among healthcare professionals, are sustaining the market's growth trajectory. Lastly, the impact of COVID-19 on elective surgeries has underscored the need for mobile and resilient imaging solutions, further accelerating market expansion.

Report Scope

The report analyzes the Fluoroscopy and Mobile C-Arms market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Type (Fixed C-Arms Type, Mobile C-Arms Type); Technology (Digital Fluoroscopy Technology, Analog Fluoroscopy Technology, Hybrid Fluoroscopy Technology); Application (Orthopedic Surgery Application, Cardiovascular Surgery Application, Neurosurgery Application, Gastroenterology Application, Urology Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Imaging Centers End-Use, Research Institutions End-Use).
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Fixed C-Arms Type segment, which is expected to reach US$3.5 Billion by 2032 with a CAGR of a 10.4%. The Mobile C-Arms Type segment is also set to grow at 6.4% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $800.6 Million in 2025, and China, forecasted to grow at an impressive 8.6% CAGR to reach $877.6 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Fluoroscopy and Mobile C-Arms Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Fluoroscopy and Mobile C-Arms Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Fluoroscopy and Mobile C-Arms Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as GE Healthcare, Hologic, Inc., OrthoScan, Inc., Philips Healthcare, Shimadzu Corporation and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Fluoroscopy and Mobile C-Arms market report include:

• GE Healthcare
• Hologic, Inc.
• OrthoScan, Inc.
• Philips Healthcare
• Shimadzu Corporation
• Siemens Healthineers
• Ziehm Imaging GmbH

What Sets This Report Apart From Others?

• Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
• Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
• Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
• Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
• Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
• Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.